{"basic_info": {"ticker": "300255", "exchange": "XSHE", "bloomberg_ticker": "300255 CH Equity", "name": "HEBEI CHANGSHAN BIOCHEMICA-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "常山药业", "period": "2020", "market_value": 5759395840, "total_income": 1009847609, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 893761991, "business_income_over_total_income": 0.8850464001049092}, {"shariah_compliance": "unknown", "income": 116085617, "business_income_over_total_income": 0.11495359890484229}], "details": [{"business_activity_cn": "普通肝素原料药", "business_activity_en": "Unfractionated heparin API", "income": 313832307, "business_income_over_total_income": 0.3107719463838429, "shariah_compliance": "compliant"}, {"business_activity_cn": "低分子肝素制剂", "business_activity_en": "Low molecular weight heparin preparations", "income": 579929684, "business_income_over_total_income": 0.5742744537210663, "shariah_compliance": "compliant"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 115567142, "business_income_over_total_income": 0.11444017985489928, "shariah_compliance": "unknown"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 518475, "business_income_over_total_income": 0.0005134190499430098, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.19061017383875636, "shariah_compliance": "compliant", "amount_over_market_value": 0.19061017383875636}]}